Yoichi Furuya
2PUBLICATIONS
0CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (2)
Sort by Publication Date:
|Sep 01, 2021
The Interleukin-33-Group 2 Innate Lymphoid Cell Axis Represents a Potential Adjuvant Target To Increase the Cross-Protective Efficacy of Influenza Vaccine.Clare M Williams, Sreeja Roy, Danielle Califano
|Jul 12, 2021
Detrimental impact of allergic airway disease on live attenuated influenza vaccine.Sreeja Roy, Clare M Williams, Yoichi Furuya
Pageof 1
